Key Highlights

  • OneSpan shares are trading up 31.51% at $26.50 after the company raised 2026 Revenue guidance to $254 million to $258 million.
  • CareDx shares are trading up 21.56% at $86.94 after third-quarter revenue rose 39% to $139.4 million.
  • BrightSpring Health Services reported third-quarter revenue of $4.213 billion, up 26.4% from a year earlier.
  • ACCO Brands shares are trading up 20.18% at $5.24, and 2026 adjusted Earnings guidance rose to $0.98 to $1.02 per share.
  • Civeo shares are trading up 19.77% at $36.59 after revenue guidance was lifted to $710 million to $720 million.

Which Stocks Are Rising After Raised Guidance or Strong Quarterly Results Today?

Five companies that reported third-quarter results on Oct 29, 2026 are trading sharply higher on Oct 30, 2026. OneSpan (NASDAQ:OSPN) is trading up 31.51% at $26.50, and CareDx (NASDAQ:CDNA) is trading up 21.56% at $86.94. BrightSpring Health Services (NASDAQ:BTSG) is trading up 13.83% at $68.55.

ACCO Brands (NYSE:ACCO) is trading up 20.18% at $5.24, and Civeo (NYSE:CVEO) is trading up 19.77% at $36.59. Each percentage is measured against that company's own prior close, so the bases differ, and the order here follows the theme rather than the size of the move.

Every company in the group raised at least part of its full-year outlook alongside the quarterly report. For BrightSpring, the source did not give the prior guidance ranges, so the raise is described only in general terms. In several cases the results are assumed to be the driver of the move, since the companies reported the day before.

OneSpan: how much did the raised outlook outweigh the Rosenblatt downgrade?

OneSpan reported third-quarter revenue up 12% to $63.9 million, with subscription revenue up 16% to $51.5 million. The company raised 2026 revenue guidance to $254 million to $258 million from $248 million to $252 million, and adjusted EBITDA guidance to $72 million to $76 million from $67 million to $71 million.

The move comes despite a downgrade from Rosenblatt on Oct 27, which cut the rating to Neutral from Buy, citing valuation ahead of earnings. The filing held only the earnings release, with no Leadership or deal news, which points to the numbers and the higher outlook as the main drivers. Net Income was $7.8 million, or $0.20 per diluted share, and annual Recurring Revenue reached $195.5 million, up 9%. OneSpan provides digital identity, authentication and e-signature products, and its board declared a quarterly Dividend of $0.13 per share.

CareDx: what is behind a 39% revenue jump and a higher EBITDA target?

CareDx reported third-quarter revenue of $139.4 million, up 39% from $100.1 million, led by Testing Services revenue of $119.2 million, up 65%. Adjusted EBITDA doubled to $30.5 million, and GAAP net income was $19.3 million, or $0.35 per diluted share.

The company raised 2026 revenue guidance to $520 million to $530 million from $490 million to $500 million, and adjusted EBITDA guidance to $90 million to $100 million from $66 million to $78 million. The mix changed after the July 1 Acquisition of Naveris and the June 30 sale of its Lab Products business. Cash ended September at $250.5 million, up from $65.4 million at the end of 2025, and free Cash Flow for the quarter was $11.1 million.

BrightSpring Health Services: why is the stock nearing its 52-week high?

BrightSpring Health Services reported third-quarter revenue of $4.213 billion, up 26.4%, and adjusted EBITDA of $228 million, up 42.0%. Adjusted Earnings Per Share were $0.54, compared with $0.30 a year earlier. The shares sit within about 7% of a 52-week high of $73.75.

Guidance now calls for 2026 revenue of $15.900 billion to $16.125 billion and adjusted EBITDA of $850 million to $860 million, excluding the Community Living Business sold on Mar 30, 2026. Leverage fell to 1.79 times from 2.15 times at the end of June, and cash stood at $717.8 million. The company provides home and community-based services through pharmacy, home health and rehabilitation operations. Market Value of about $12.68 billion is a pre-move figure from Oct 23.

ACCO Brands: how much of the earnings rise came from Tariff refunds?

ACCO Brands reported third-quarter adjusted earnings per share of $0.28, up from $0.21, and that figure included about $0.11 per share from net tariff refunds. Net sales slipped 0.9% to $380.3 million, while adjusted EBITDA reached $55.4 million, a 14.6% margin.

The company raised 2026 adjusted earnings per share guidance to $0.98 to $1.02, including $0.12 from the tariff refund, with free cash flow of about $100 million. It completed the Trust acquisition on Oct 1, which the company expects to lift pro forma tech peripherals sales toward $500 million. ACCO makes workplace and school products. The shares now sit above a prior 52-week high of $4.74, and the market value of about $432 million is from last week's data.

Civeo: how are Canadian contracts supporting the guidance raise?

Civeo reported third-quarter revenue up 13% to $193.1 million and net income of $5.2 million, or $0.50 per diluted share, against a small loss a year earlier. Canadian revenue rose 38% to $63.6 million, and the company secured contracts covering about 700 mobile fleet rooms since the end of the second quarter.

Revenue guidance for 2026 moved to $710 million to $720 million from $675 million to $700 million, and adjusted EBITDA guidance to $89 million to $92 million. Capital spending guidance rose to $30 million to $35 million. Net Debt was $196.0 million, the net Leverage Ratio was 2.1 times. The company runs workforce lodging in Australia and the Canadian oil sands, and the stock is just above a prior 52-week high of $36.50.

How the Gains Compare: Spread, Average and Guidance Increases

The gains run from 13.83% for BrightSpring Health Services to 31.51% for OneSpan, a calculated spread of 17.68 percentage points. The calculated average of the five moves is 21.37%. Three of the five sit in a narrow band between 19.77% and 21.56%.

Guidance increases vary in size. Measured at the midpoint, OneSpan's revenue outlook is a calculated 2.4% higher, CareDx's is a calculated 6.1% higher and Civeo's is a calculated 4.0% higher. CareDx at $86.94 trades at a calculated 16.6 times the price of ACCO Brands at $5.24.

What to Watch Next: Dividend Dates and 2027 Product Launches

OneSpan has a Record Date of Nov 13, 2026 and a payment date of Dec 4, 2026 for its $0.13 dividend, plus a free trial of DigipassONE Authenticate planned for November 2026. ACCO Brands has a dividend record date of Nov 20 and payment on Dec 9, and it is hosting its earnings webcast today.

CareDx plans a commercial launch of AlloHeme in the first quarter of 2027. No dated release was identified for BrightSpring Health Services or Civeo beyond their next quarterly reports. The focus for BrightSpring is the closing of pending acquisitions, and for Civeo the pace of Canadian room deployments.